FrançaisAre analysts right about Exelon (EXC)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Exelon, we replayed every analyst price target of the past 12 months and measured the real outcome: 25% were profitable, average return +2% (187 calls). At 3 months: -0% average return (33% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 42 | 40% | +8% |
| Jefferies | 14 | 7% | -7% |
| Mizuho | 14 | 7% | -12% |
| Barclays | 13 | 31% | +10% |
| Deutsche Bank | 12 | 0% | -1% |
Valuation
Is Exelon overvalued, and is it a good time to buy Exelon right now? If you're wondering, here's a recap to make up your own mind: Exelon's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Exelon | Sector median (Utilities) |
|---|---|---|
| P/E | 16.3 | 20.9 |
| Forward P/E | 14.5 | 16.9 |
| Net margin | 11% | 14% |
👉 Exelon trades below its sector median (16.3 vs 20.9) — potentially undervalued, or lower expected growth.
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : Exelon pays about $1.64/share/yr → 3.55% yield. what is this?
Frequently asked questions
Is Exelon a buy right now?
The analyst consensus on Exelon (EXC) is "Hold" (13 bullish, 4 bearish calls over 12 months). This is not advice: historically, 25% of their targets on this stock turned out profitable over 1 year.
What is Exelon's price target?
The median 12-month price target is $49.00 (+12% vs $43.96), ranging from $41.00 to $58.00 (11 analysts).
Are analysts accurate on Exelon?
Over 1 year, 25% of analyst targets on Exelon were profitable, for an average return of +2% (across 187 timestamped calls). This is JPI Invest's accuracy metric.
What is the Exelon stock forecast?
Analysts target a median of $49.00 within 12 months, i.e. +12% vs the current price. The most bullish targets $58.00, the most cautious $41.00.
What is the Exelon stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $49.00, +12%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (25%), and the stock's past trajectory.
Is Exelon overvalued?
Its P/E is 16.3, forward P/E 14.5. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Exelon →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.